Moldova

Reimbursed Care Access

Moldova maintains a restrictive, controlled regime for classic psychedelics: most tryptamines, phenethylamines and plant preparations are listed under national narcotics/psychotropes legislation and have no authorised medical use outside research. Ketamine is an established, regulated anesthetic in clinical practice and is available in hospitals under the national medicines regulator; however, psychedelic/psychiatric uses of ketamine and all other classic psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, ayahuasca, mescaline, 2C‑X) are not part of reimbursed, routine public mental‑health care and are limited to approved clinical research or are outright illegal. Regulatory oversight is exercised by the Agency of Medicines and Medical Devices (Agenția Medicamentului şi Dispozitivelor Medicale, AMDM) and narcotics/psychotropic substances are controlled under Law No. 382/1999 and the Governmental List (Hotărârea nr.79/2006). [https://amdm.gov.md/public/en/about|AMDM — About] [https://ro.scribd.com/document/12659744/1045|Hotărârea nr.79/2006 and Legea nr.382/1999 (text collection)].